ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Pci Biotech Holding Asa

Pci Biotech Holding Asa (0JGL)

51,00
0,00
( 0,00% )
Aktualisiert: 01:00:00

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
51,00
Gebot
0,00
Fragen
0,00
Volumen
0,00
0,00 Tagesbereich 0,00
51,00 52-Wochen-Bereich 51,00
Marktkapitalisierung
Handelsende
51,00
Handelsbeginn
-
Letzte Trade
(O)
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
0,00
Ausgegebene Aktien
37.326.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-93,70
Gewinn pro Aktie (EPS)
-0,54
Erlöse
2,99M
Nettogewinn
-20,32M

Über Pci Biotech Holding Asa

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Lysaker, Nor
Gegründet
-
Pci Biotech Holding Asa is listed in the Pharmaceutical Preparations sector of the Londoner Börse with ticker 0JGL. The last closing price for Pci Biotech Holding Asa was kr51,00. Over the last year, Pci Biotech Holding Asa shares have traded in a share price range of kr 51,00 to kr 51,00.

Pci Biotech Holding Asa currently has 37.326.000 shares in issue. The market capitalisation of Pci Biotech Holding Asa is kr1,90 billion. Pci Biotech Holding Asa has a price to earnings ratio (PE ratio) of -93.70.

0JGL Neueste Nachrichten

PCI Biotech: Employee share option scheme

PCI Biotech: Employee share option scheme Oslo, 2 September 2024 - PCI Biotech (OSE: PCIB), today announce that the Board of Directors has granted share options to key employees.         In...

PCI Biotech first half 2024 interim results

PCI Biotech first half 2024 interim results Oslo (Norway), 28 August 2024 – PCI Biotech (OSE: PCIB), today announces its interim first half 2024 results. Please find enclosed the interim report...

PCI Biotech: Invitation to first half interim 2024 results presentation

PCI Biotech: Invitation to first half interim 2024 results presentation Oslo, Norway, 23 August 2024 - PCI Biotech (OSE: PCIB) invites to a webcast presentation of the company's first half 2024...

Minutes of Annual General Meeting 2024

Minutes of Annual General Meeting 2024 Oslo, 24 May 2024. The Annual General Meeting in PCI Biotech Holding ASA took place today, 24 May 2024. All the matters on the agenda were approved and the...

Disclosure of voting rights for Chair of the Board

Disclosure of voting rights for Chair of the Board Oslo, 23 May 2024. PCI Biotech Holding ASA ("PCI Biotech" or the "Company") issue this notification on behalf of Hans Peter Bøhn, Chair of the...

PCI Biotech Holding ASA - Notice of Annual General Meeting 2024

PCI Biotech Holding ASA - Notice of Annual General Meeting 2024 Oslo, Norway 3 May 2024 - The annual general meeting of PCI Biotech Holding ASA will be held at the company’s office at Oslo Cancer...

PCI Biotech Holding ASA - Annual Report 2023

PCI Biotech Holding ASA - Annual Report 2023 Oslo, Norway, April 26, 2024.The Board of Directors of PCI Biotech Holding ASA has approved the Annual Report 2023. Please find the report attached, as...

PCI Biotech second half 2023 interim results

PCI Biotech second half 2023 interim results Oslo (Norway), 14 February 2024 – PCI Biotech (OSE: PCIB), today announces its interim second half 2023 results. Please find enclosed the interim...

PCI Biotech: Invitation to second half interim 2023 results presentation

PCI Biotech: Invitation to second half interim 2023 results presentation Oslo, Norway, 12 February 2024 - PCI Biotech (OSE: PCIB) invites to a webcast presentation of the company's second half...

PCI Biotech initiates field testing of its proprietary technology for gene therapy manufacturing

PCI Biotech initiates field testing of its proprietary technology for gene therapy manufacturing Oslo, Norway, 13 October 2023 – PCI Biotech (OSE: PCIB) today announced a research...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10051515100DE
40051515100DE
120051515100DE
26005151512451DE
52005151511351DE
1560051515186051DE
2600051515179851DE
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
FARFerro-alloy Resources Limited
6,75p
(187,23%)
38,45M
VELAVela Technologies Plc
0,0075p
(36,36%)
302,56M
ROCRockpool Acquisitions Plc
2,25p
(28,57%)
150k
RCGHRc365 Holding Plc
1,60p
(28,00%)
3,27M
CASPCaspian Sunrise Plc
3,50p
(25,00%)
10,88M
NTOGNostra Terra Oil And Gas Company Plc
0,02325p
(-38,00%)
1,06B
CNNCaledonian Trust Plc
35,00p
(-36,36%)
98,57k
PPSProton Motor Power Systems Plc
0,125p
(-30,56%)
6,8M
SLFRSlf Realisation Fund Limited
1,02p
(-27,66%)
471,52k
QUIZQuiz Plc
4,02p
(-23,43%)
18,99k
NTOGNostra Terra Oil And Gas Company Plc
0,02325p
(-38,00%)
1,06B
NTVONativo Resources Plc
0,0023p
(0,00%)
517,78M
TRPTower Resources Plc
0,028p
(1,82%)
466,76M
VELAVela Technologies Plc
0,0075p
(36,36%)
302,56M
HAYDHaydale Graphene Industries Plc
0,115p
(0,00%)
269,29M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen